C4 Therapeutics, Inc. · NASDAQ:CCCC
Adams Kendra exercised options for 6,250 C4 Therapeutics, Inc. shares (Form 4)
Traded Sep 18, 2026 · Filed Sep 21, 2026
On Sep 18, 2026, Adams Kendra (Chief Financial Officer) exercised options for 6,250 C4 Therapeutics, Inc. shares, leaving 382,323 shares. Filed Sep 21, 2026 (Form 4).
- Options exercised
- 6,250 shares
- Holding after
- 382,323 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Stock | Option exercise | 6,250 | 385,098 | Direct | |
| Sep 18, 2026 | Common Stock | Shares withheld for tax | 2,775 | US$3.39 | 382,323 | Direct |
Source
Related
- C4 Therapeutics, Inc.
- Adams Kendra
- C4 Therapeutics, Inc. shareholders
- Form 4 · Anderson Kenneth Carl · Oct 2, 2026
- Form 4 · Grogan Donna Roy · Oct 2, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026